Company news
Shionogi & Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Shionogi & Co., Ltd. - Exclusive Licensing Agreement with Link Healthcare, a Clinigen Company for Cefiderocol in Australia and New Zealand
April 3, 2025
Shionogi & Co., Ltd. - Approval for Fetroja in South Korea
February 24, 2025
Shionogi Obtains Domestic Manufacturing and Marketing Approval for the Digital Therapeutic App ENDEAVORRIDE for Pediatric Attention-Deficit, Hyperactivity Disorder
February 19, 2025
Calls
The 5 newest of 7 calls. Every call is listed under its year.
- Shionogi & (Tokyo:4507) Q3 2024 Earnings Call
Jan 31, 2025
Transcript - Shionogi & (Tokyo:4507) Q2 2024 Earnings Call
Oct 29, 2024
Transcript - Shionogi & (Tokyo:4507) Q1 2024 Earnings Call
Jul 29, 2024
Transcript - Shionogi & (Tokyo:4507) Q2 2023 Earnings Call
Nov 1, 2023
Transcript - Shionogi & (Tokyo:4507) Q1 2023 Earnings Call
Jul 31, 2023
Transcript
Decks
The 5 newest of 39 decks. Every deck is listed under its year.
- H1 FY2026 Earnings Presentation
Earnings · 44 slides · Oct 29, 2026
- Q1 FY2026 Earnings Presentation
Earnings · 44 slides · Aug 3, 2026
- FY2025 Earnings Presentation
Earnings · 50 slides · May 12, 2026
- FY2025 Earnings Presentation
Earnings · 50 slides · May 12, 2026
- Q3 FY2025 Earnings Presentation
Earnings · 34 slides · Jan 30, 2026